Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329211 · ClinicalTrials.gov registry record
Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 68
- Enrollment target
NCT01329211: Clinical Trial study, sponsored by University of Florida.
NCT01329211 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01329211 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The project will involve conducting a Needs Assessment for Gastroparesis patients and their caregivers with the goal of identifying quality of life issues associated with this disease. Identifying these issues will ameliorate management and support systems for gastroparesis currently existent in the community and, hopefully, provide information for the establishment of more resources to assist the patients and their families.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-02 |
Why NCT01329211 stopped before completion
NCT01329211 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01329211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01329211 about?
NCT01329211 is a clinical study titled "Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers". The project will involve conducting a Needs Assessment for Gastroparesis patients and their caregivers with the goal of identifying quality of life issues associated with this disease. Identifying these issues will ameliorate management and support systems for gastroparesis currently existent in the...
What is the current status of trial NCT01329211?
This trial is currently terminated. The enrollment target is 68 participants. The study started on 2010-01. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01329211?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia